Cargando…

Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor

Detalles Bibliográficos
Autores principales:	Andrabi, Raiees, Makhdoomi, Muzamil, Luthra, Kalpana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847999/ http://dx.doi.org/10.1186/1742-4690-10-S1-P52

Ejemplares similares

Cross clade reactive plasma anti-V3 antibodies in human immunodeficiency virus type-1 infected individuals develop with time
por: Andrabi, Raiees, et al.
Publicado: (2012)

Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors
por: Andrabi, Raiees, et al.
Publicado: (2012)

Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India
por: Andrabi, Raiees, et al.
Publicado: (2012)

Generation and characterization of human monoclonal single chain variable fragments (scFvs) against envelope third variable region (V3) of HIV-1 clade C
por: Kumar, Rajesh, et al.
Publicado: (2012)

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization
por: Andrabi, Raiees, et al.
Publicado: (2012)

Production and expression of recombinant anti-V3 scFvs from HIV-1 clade C infected Indian patient
por: Kumar, Rajesh, et al.
Publicado: (2012)

Cross-clade neutralization potential of the plasma of antiretroviral naïve HIV-1 infected children from north India
por: Sankaran, Prakash Somi, et al.
Publicado: (2012)

Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual
por: Khan, Lubina, et al.
Publicado: (2015)

Highly efficient neutralization of human immunodeficiency viruses by plasma from antiretroviral drug treated patients is mediated by IgG fractions
por: Andrabi, R, et al.
Publicado: (2012)

A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C
por: Kumar, Rajesh, et al.
Publicado: (2012)

Production of cross neutralizing single chain fragment variables (scFv) from HIV-1 infected Indian children
por: Kumar, Sanjeev, et al.
Publicado: (2014)

DC SIGNR silencing reduces HIV-1 infection in Dendritic cells
por: Chaudhary, Omkar, et al.
Publicado: (2014)

Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naïve and Treated Pediatric Patients
por: Bure, Dinesh, et al.
Publicado: (2015)

CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children
por: Kumar, Sanjeev, et al.
Publicado: (2017)

Construction of site selected phage library and characterization of anti-V3 scFvs from Indian clade C HIV-1 infected patient
por: Kumar, R, et al.
Publicado: (2012)

Plasma antibodies that cross react to subtype-B and C third variable (V3) region develop in Indian HIV-1 infected iIndividuals with time
por: Andrabi, R, et al.
Publicado: (2012)

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections
por: Njai, HF, et al.
Publicado: (2009)

A comprehensive binding and neutralization analysis of plasma of HIV-1 subtype-C infected donors from India suggest MPER directed neutralization
por: Andrabi, R, et al.
Publicado: (2012)

P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
por: Gorny, MK, et al.
Publicado: (2009)

Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide
por: Matyas, GR, et al.
Publicado: (2012)

Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection
por: Mishra, Nitesh, et al.
Publicado: (2020)

Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
por: Saxena, Latika, et al.
Publicado: (2015)

Challenges in integrating component level technology and system level information from Ayurveda: Insights from NMR phytometabolomics and anti-HIV potential of select Ayurvedic medicinal plants
por: Jayasundar, Rama, et al.
Publicado: (2019)

Relative reduction of plasmacytoid dendritic cells with shift in TH(1) to TH(2) response in HIV-1 infected patients as compared to high risk and healthy north Indians
por: Chaudhary, Omkar, et al.
Publicado: (2012)

An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1
por: Kumar, Sanjeev, et al.
Publicado: (2023)

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target
por: Phogat, SK, et al.
Publicado: (2009)

MINOS: Bt 599 intérieur - Bt 904
Publicado: (1992)

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

P04-03. Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donors
por: Binley, J, et al.
Publicado: (2009)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies
por: Crickard, Lindsay, et al.
Publicado: (2012)

Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera
por: Matsuno, H, et al.
Publicado: (2003)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
por: Spearman, P, et al.
Publicado: (2012)

2593. Human Monoclonal Antibodies Potently Neutralize Enterovirus D68 in both a Clade-Specific and -Independent Manner
por: Vogt, Matthew R, et al.
Publicado: (2019)

Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120
por: Chen, Hongying, et al.
Publicado: (2008)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46
por: Saito, Mineki, et al.
Publicado: (2014)

P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β
por: Weaver, KL, et al.
Publicado: (2009)

Monoclonal antibodies for the therapy of cancer
por: Simpson, Andrew, et al.
Publicado: (2014)

Work on CMS Muon Detector (RPC) during Long Shutdown 1 (LS1) - building 904, Prevessin
por: Dong Hyun, Kim
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_750baktqh457e2rb7to14l0lqs